Our study reveals that several immune cells displayed dysregulated levels between the MS samples and normal samples, such as naive B cells, CD8 T cells, CD4 naive T cells, regulatory T cells (Tregs), gamma delta T cells, monocytes, M0 macrophages, and M2 macrophages (Figure 7B). The gene discussed is CD8A; the disease is myeloid sarcoma.